NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 5.03% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.75% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 4.44% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 4.38% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.33% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 4.15% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.90% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.80% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 3.64% |
| DYN | Dyne Therapeutics Inc | Healthcare | Biotechnology | 3.50% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 3.43% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.42% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.42% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.32% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.24% |